Where Melanotan II Stands With the FDA Today
Melanotan II has no FDA approval. In April 2026, FDA took it off a list of compounding substances with safety concerns after the request for review was withdrawn. That step did not approve it, and US pharmacies still cannot compound it. An FDA advisory committee is expected to review it by early 2027. FDA has also cited published case reports of serious events, including melanoma, priapism and a brain swelling condition called PRES.
Because Unify Care prescribes only FDA-approved peptides, Melanotan II is not something we can prescribe. What we can do is assess your health, explain approved options and watch for problems if you keep using it.

.png)
.png)
.png)

